Evidence map›Paper›PMID 42661631›Full record

ArticleFrontiers in oncology2026

Case Report:

John Jairo Suárez, Jennyfer Benavides, Andrea Catalina Rubio-Vargas, Paul C Lott, Alejandro Vélez, Jorge Mario Castro, Antonio Huertas, Magdalena Echeverry de Polanco, Luis G Carvajal-Carmona, Mabel Bohórquez

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

John Jairo Suárez *Cytogenetics, Phylogeny and Population Evolution Group, Faculty of Sciences and Faculty of Health Sciences, University of Tolima, Ibagué, Colombia.
Jennyfer Benavides *Cytogenetics, Phylogeny and Population Evolution Group, Faculty of Sciences and Faculty of Health Sciences, University of Tolima, Ibagué, Colombia.
Andrea Catalina Rubio-VargasCytogenetics, Phylogeny and Population Evolution Group, Faculty of Sciences and Faculty of Health Sciences, University of Tolima, Ibagué, Colombia.
Paul C LottGenome Center, Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Davis, United States.
Alejandro VélezPablo Tobón Uribe Hospital, Dinámica Laboratory, Medellín, Colombia.
Jorge Mario CastroFederico Lleras Acosta Hospital, Ibagué, Colombia.
Antonio HuertasNational Cancer Institute, Bogotá, Colombia.
Magdalena Echeverry de PolancoCytogenetics, Phylogeny and Population Evolution Group, Faculty of Sciences and Faculty of Health Sciences, University of Tolima, Ibagué, Colombia.
Luis G Carvajal-CarmonaGenome Center, Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Davis, United States.
Mabel BohórquezCytogenetics, Phylogeny and Population Evolution Group, Faculty of Sciences and Faculty of Health Sciences, University of Tolima, Ibagué, Colombia.

Funding

UC Davis Multi-Disciplinary Cancer Research Training Program to Advance Precision Cancer Prevention and Care in Latin America.D43CA260869 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Luis Guillermo Carvajal Carmona, Laura Fejerman · 2022 to 2026
$1.2M
NCI NIH HHS D43 CA260869
6 · The paper itself

Abstract

Introduction: Juvenile polyposis syndrome (JPS) is a rare autosomal-dominant disorder characterized by numerous juvenile hamartomatous polyps in the gastrointestinal tract (GIT), increasing cancer risk. Pathogenic and likely pathogenic (P/LP) variants in the Case description: This case involves a 62-year-old Colombian woman with multiple colorectal polyps. Family history included gastric cancer in the mother and the paternal grandmother, and colorectal polyps in two sisters and one daughter. Results: Germline testing of the proband identified a novel heterozygous frameshift variant in exon 11 of Conclusion: Germline genetic testing revealed for the first time the presence of a possible novel

Indexed as

BMPR1A and BARD1 genesframeshift insertiongermline variantsjuvenile polyposis syndromepremature stop codon

Identifiers

PMID42661631
PMCPMC13518129

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.